SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-023215
Filing Date
2021-04-28
Accepted
2021-04-28 11:43:47
Documents
24
Period of Report
2021-04-28
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea140000-8k_inmedpharma.htm 8-K 31085
2 CORPORATE PRESENTATION UTILIZED APRIL 28, 2021 ea140000ex99-1_inmed.htm EX-99.1 26761
3 GRAPHIC ex99-1_001.jpg GRAPHIC 379056
4 GRAPHIC ex99-1_002.jpg GRAPHIC 545232
5 GRAPHIC ex99-1_003.jpg GRAPHIC 279935
6 GRAPHIC ex99-1_004.jpg GRAPHIC 426614
7 GRAPHIC ex99-1_005.jpg GRAPHIC 474285
8 GRAPHIC ex99-1_006.jpg GRAPHIC 417320
9 GRAPHIC ex99-1_007.jpg GRAPHIC 159061
10 GRAPHIC ex99-1_008.jpg GRAPHIC 314423
11 GRAPHIC ex99-1_009.jpg GRAPHIC 379047
12 GRAPHIC ex99-1_010.jpg GRAPHIC 304236
13 GRAPHIC ex99-1_011.jpg GRAPHIC 361400
14 GRAPHIC ex99-1_012.jpg GRAPHIC 373317
15 GRAPHIC ex99-1_013.jpg GRAPHIC 190312
16 GRAPHIC ex99-1_014.jpg GRAPHIC 409644
17 GRAPHIC ex99-1_015.jpg GRAPHIC 386700
18 GRAPHIC ex99-1_016.jpg GRAPHIC 352634
19 GRAPHIC ex99-1_017.jpg GRAPHIC 148352
20 GRAPHIC ex99-1_018.jpg GRAPHIC 474374
21 GRAPHIC ex99-1_019.jpg GRAPHIC 331309
22 GRAPHIC ex99-1_020.jpg GRAPHIC 495368
23 GRAPHIC ex99-1_021.jpg GRAPHIC 431511
24 GRAPHIC ex99-1_022.jpg GRAPHIC 211843
  Complete submission text file 0001213900-21-023215.txt   10781191
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39685 | Film No.: 21862626
SIC: 2834 Pharmaceutical Preparations